Literature DB >> 26977007

Tumour-Endothelial Cell Communications: Important and Indispensable Mediators of Tumour Angiogenesis.

Bruno Miguel Lopes-Bastos1, Wen G Jiang1, Jun Cai2.   

Abstract

Angiogenesis is an essential aspect of tumour growth and metastasis. Solid tumours cannot grow beyond 2-3 mm in diameter without inducing the formation of new blood vessels to support the energetic requirements of tumour cells. Angiogenesis is stimulated by cancer cells through a wide variety of cell-to-cell communication means. Cancer cells can induce endothelial changes by directly targeting cells via soluble factors, adhesion receptors, gap junctions and vesicles. They also can stimulate endothelial signaling pathways in an indirect way, e.g. by activating stromal cells, by secreting proteases into the extracellular space or even by changing the pH, temperature and availability of oxygen and nutrients. Anti-angiogenic drugs appear to be an effective cancer treatment in animal models but have been shown to have a limited effect in the long term. Resistance to anti-angiogenic therapies has been attributed to the ability of cancer cells to induce angiogenesis in a different way. We propose that cancer cells also change the way they communicate with endothelial cells in order to escape therapies that inhibit angiogenesis and that a better knowledge of this phenomenon will help us design more efficient drugs. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Cell-to-cell communication; anti-angiogenic therapy; drug resistance; review; tumour angiogenesis

Mesh:

Substances:

Year:  2016        PMID: 26977007

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  24 in total

Review 1.  Pyruvate Kinase M2: a Metabolic Bug in Re-Wiring the Tumor Microenvironment.

Authors:  Mohd Rihan; Lakshmi Vineela Nalla; Anil Dharavath; Amit Shard; Kiran Kalia; Amit Khairnar
Journal:  Cancer Microenviron       Date:  2019-06-10

2.  Clinical significance of 5-(and 6)-carboxyfluorescein diacetate succinimidyl ester-labeled microspheres for detecting endothelial progenitor cells in human peripheral blood.

Authors:  Chaolin Qiu; Denghai Zhang; Yongbin Chi; Qing Chen; Limin Xu; Qiuhua Xie
Journal:  Exp Ther Med       Date:  2017-06-23       Impact factor: 2.447

Review 3.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

4.  [99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor.

Authors:  Sajad Kaihani; Nourollah Sadeghzadeh; Saeid Abediankenari; Seyed Mohammad Abedi
Journal:  Ann Nucl Med       Date:  2022-09-12       Impact factor: 2.258

5.  Efficacy Investigation of TACE Combined with Lenvatinib and Sintilimab in Intermediate-Stage Hepatocellular Carcinoma.

Authors:  Menglong Zhang; Weiguo Lai; Jian Zhang; Bijuan Hu; Liyin Huang; Cunkun Chu
Journal:  Dis Markers       Date:  2022-07-06       Impact factor: 3.464

6.  Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes.

Authors:  Matthew L Scott; David T Coleman; Kinsey C Kelly; Jennifer L Carroll; Brittany Woodby; William K Songock; James A Cardelli; Jason M Bodily
Journal:  Virology       Date:  2018-03-31       Impact factor: 3.616

Review 7.  Systems biology of angiogenesis signaling: Computational models and omics.

Authors:  Yu Zhang; Hanwen Wang; Rebeca Hannah M Oliveira; Chen Zhao; Aleksander S Popel
Journal:  WIREs Mech Dis       Date:  2021-12-30

8.  Dicer suppresses MMP-2-mediated invasion and VEGFA-induced angiogenesis and serves as a promising prognostic biomarker in human clear cell renal cell carcinoma.

Authors:  Yan-Su Chen; Fei Meng; Hai-Long Li; Qing-Hua Liu; Ping-Fu Hou; Jin Bai; Jun-Nian Zheng
Journal:  Oncotarget       Date:  2016-12-20

Review 9.  Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning.

Authors:  Sigrid A Langhans
Journal:  Front Pharmacol       Date:  2018-01-23       Impact factor: 5.810

Review 10.  Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.

Authors:  Ana Cavaco; Maryam Rezaei; Stephan Niland; Johannes A Eble
Journal:  Int J Mol Sci       Date:  2017-11-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.